Introduction {#S1}
============

Dry eye disease (DED) is one of the most common ocular surface diseases, with a prevalence of 20--50%, and is becoming a significant global health problem ([@B25]; [@B33]). The Tear Film and Ocular Surface Dry Eye Workshop II (TFOS DEWS II) in 2017 provided a new definition: "Dry eye is a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film, and accompanied by ocular symptoms, in which tear film instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities play etiological roles ([@B38])." DED has a marked negative impact on the physical ([@B33]) and psychosomatic ([@B2]; [@B17]) well-being of patients and exerts a substantial economic impact ([@B41]).

Despite its prevalence and impact, there is no "gold standard" diagnostic test for DED ([@B37]; [@B35]). According to a report from the 2017 TFOS DEWS II, a diagnostic test battery for DED, including the screening 5-Item Dry Eye Questionnaire (DEQ-5) and Ocular Surface Disease Index (OSDI), confirms that a patient may have DED and triggers the diagnostic testing of non-invasive breakup time, osmolarity, and ocular surface staining with fluorescein and lissamine green ([@B38]). The DEQ-5 and OSDI questionnaires are used by patients to self-assess the symptoms, frequency, and severity of dry eye. Although the questionnaire score can roughly distinguish between dry eyes and non-dry eyes, a study conducted by [@B23] showed that the perception of dry eye symptoms is not obvious due to lower corneal sensitivity. It is also affected by subjectivity, level of education, living environment, etc. Usually, the measurement of the tear film breakup time is the most frequent test of tear film stability in clinical practice. The measurement of non-invasive breakup time depends on the inspection equipment. Hence, the easy-to-operate fluorescein breakup time (FBUT) is most commonly used; however, it is affected by fluorescein, temperature, humidity, air circulation, etc. While osmolarity is considered the most relevant factor to the severity of dry eye, it is rarely used in outpatient clinics due to the high requirement for consumables and their instability. Ocular surface staining is a late feature of dry eye syndrome and a marker for the clinical diagnosis of severe dry eye syndrome, which has no significant value for the diagnosis of early dry eye. In summary, the above diagnostic methods are characterized by limitations for the diagnosis of dry eye. Therefore, the development of a diagnostic method with precise, stable, sensitive, specific, and convenient operation is urgently warranted.

Metabolomics is defined as the simultaneous qualitative and quantitative analysis of the metabolic response of living systems to pathophysiological stimuli or genetic modification. The main analytical techniques adopted in a global metabolomic analysis are nuclear magnetic resonance spectroscopy and mass spectrometry (MS) ([@B42]). MS is usually combined with different separation techniques, such as liquid chromatography (LC) ([@B19]), gas chromatography ([@B4]), and capillary electrophoresis ([@B28]), to enhance sensitivity. In the last 10 years, many studies have investigated the metabolite composition of the cornea, lens, and vitreous humor ([@B40]). Metabolomics has been used in clinical and animal studies of several eye diseases, including diabetic retinopathy ([@B7]), age-related macular degeneration ([@B5]), glaucoma ([@B1]), keratoconus ([@B18]), and dry eye ([@B13]). With advances in technology, untargeted LC-MS metabolomic analysis of tear fluid in ocular diseases could be further conducted. Thus, investigations for the discovery of biomarker candidates for ocular diseases from tear fluid may also be useful for an accurate clinical diagnosis.

In the present study, we investigated alterations in the metabolic profile of tear fluid obtained from a clinical cohort of 113 subjects to detect metabolite aberrations in tears. Subsequently, all metabolites were separated by association with the clinical signs \[OSDI, FBUT, corneal fluorescein staining (FL)\] to identify the metabolites in tears that are pathologically relevant to DED. In addition, we constructed a more accurate metabolite model to assist us in the effective diagnosis of DED.

Subjects and Methods {#S2}
====================

Subjects and Groups {#S2.SS1}
-------------------

According to the diagnostic criteria and exclusion criteria for dry eye proposed in TFOS DEWS II, and considering the operability of the outpatient clinic, we used the following inclusion criterion: OSDI ≥ 13 or DEQ-5 ≥ 6. More strictly, FBUT \< 10 s and ocular surface staining (+) were met. However, any of the following conditions were excluded: history of eye medication within 1 month; active inflammation of the eye or use of contact lens within 3 months; eye trauma or surgical history within 6 months; combined with hyperthyroidism, rheumatism, dry syndrome, and other diseases affecting tear secretion; presence of life-threatening primary diseases; or participation in other clinical trials. A total of 113 subjects were included in the final population. Tear samples (the tears of both eyes were treated as one sample) were divided into two groups: 28 and 85 samples were included in the control group (CG) and dry eye group (DEG), respectively. All subjects provided written informed consent. The study complied with the tenets of the Declaration of Helsinki for the protection of human subjects in medical research. [Supplementary Table S1](#TS1){ref-type="supplementary-material"} lists the inclusion and exclusion criteria.

Sample Collection {#S2.SS2}
-----------------

Firstly, each subject completed a form that included informed consent, basic information, past history, surgical history, medication history, family history, the OSDI questionnaire, and the DEQ-5 questionnaire. The OSDI questionnaire was used to assess the effects of ocular symptoms, visual function, and environmental factors in dry eye syndrome; a score ≥13 was considered meaningful. DEQ-5 was used to assess the duration of dry eye symptoms; a score ≥6 was considered meaningful. After completion of the questionnaire, each subject underwent systematic ophthalmologic examinations, including the Schirmer I test (SIT), tear meniscus height, FBUT, FL, corneal sensitivity, and meibomian gland function. After the SIT, both strips were placed in a single cryotube as one sample and stored in a −80°C refrigerator.

Preparation of Tear Samples and Metabolomic Study {#S2.SS3}
-------------------------------------------------

The SIT strip containing tears was removed from the −80°C refrigerator and immediately dissolved in 1 ml of 80% methanol. After ultrasonication, the supernatant was centrifuged (at 4,000 rpm), dried in a vacuum concentrator, and reconstituted with 10 μl of high-performance LC double-distilled water. One microliter of the sample was used for ultraperformance liquid chromatography coupled with quadrupole/time-of-flight mass spectrometry analysis. Liquid-chromatographic separation of processed tears was performed on a 100 × 2.1-mm Zorbax Eclipse Plus 1.8-μm C18 column using a 1290 infinity system, while MS was performed on a 6545 Quadrupole-Time of Flight system (all devices from Agilent Technologies, Santa Clara, CA, United States). Samples were randomly assigned to analyses. During analysis of each sample sequence, one quality control sample was run after every 20 injections. The gradient program of elution was: 1% B at 0--1 min, 15% B at 3 min, 70% B at 5 min, 85% at 9 min, 100% at 10--12 min, and subsequently return to the initial conditions with 2 min for equilibration. The sample volume injected was 2 μl, and the flow rate was 0.4 ml/min. The MS parameters were set as follows: fragmental voltage 135 V, nebulizer gas 35 psig, capillary voltage 4,000 V, drying gas 300°C flow 6 l/min, sheath gas 340°C flow 11 l/min. The data were collected with both centroid and profile stored in autoMSMS scan mode between a mass range MS of 100--3,200 m/z and MS/MS 30--3,200 m/z using the high-resolution mode (4 GHz). Reference masses at m/z 112.05087 and 922.009798 were introduced for online accurate mass calibration.

Data Processing and Identification of Metabolites {#S2.SS4}
-------------------------------------------------

The acquired MS data (.d) were exported to mzdata format using the MassHunter Workstation software (version B.07.00; Agilent Technologies). The program XCMS was applied for data pretreatment procedures, such as peak discrimination, filtering, and alignment. After peak alignment of the data in the time domain and automatic integration and extraction of the peak intensities, a list of the intensities of all the peaks detected was generated using the retention time and the mass-to-ratio data pairs as the parameters for each ion. MS/MS spectra of the selected putative identifications were retrieved and matched with entries in the Metlin, Massbank, and HMDB databases. Open database sources, including the Kyoto Encyclopedia of Genes and Genomes and MetaboAnalyst, were used to identify metabolic pathways.

Statistical Analyses {#S2.SS5}
--------------------

Results are expressed as the mean ± standard deviation for continuous variables and as the number (percent) for categorical variables. Prior to the analysis, all metabolites were normalized to follow a normal distribution. Statistical analyses were performed using R 3.2.4. Firstly, unconditional logistic regression was performed to detect the association among metabolites and the four dry eye indexes (DEQ-5, OSDI, FBUT, and FL). Secondly, least absolute shrinkage and selection operator (LASSO) regression was conducted to detect important metabolites. Thirdly, the significant metabolic biomarker candidates were further confirmed by multiple logistic regression, with adjustment for covariates \[i.e., age, sex, and hemoglobin A1c (HbA1c) levels\]. Fourthly, the union set of metabolites associated with dry eye indexes was moved to the detection process of influence to dry eye. Two-sided *P* \< 0.05 denoted statistically significant differences, and the *P*-values for each metabolite in all comparisons were corrected by false discovery rate correction. Finally, the expression of metabolites were converted into Log2(x + 1) values to normalize non-normal distributions. The normalized data were compared by unpaired Student's *T*-test analysis.

Results {#S3}
=======

Demographic Data and Ocular Surface Parameters {#S3.SS1}
----------------------------------------------

A total of 113 subjects were enrolled in this study, with 85 patients in the DEG and 28 volunteers in the CG. The demographic data and results of ocular surface parameters are shown in [Table 1](#T1){ref-type="table"}. Briefly, there were 46.4% females in the CG and 41.2% in the DEG. The mean ages of subjects in the CG and DEG, with an unbalanced distribution, were 60.8 ± 11.2 and 55.4 ± 8.8 years, respectively (*P* \< 0.0001). The mean levels of HbA1c in the CG and DEG were 4.86% ± 0.66% and 5.446% ± 0.16%, respectively. The results of the comparison showed that the OSDI and DEQ-5 scores of patients in the DEG were higher than those recorded in the CG (*P* \< 0.0001 and *P* \< 0.0001, respectively). The patients in the DEG showed lower FBUT values and SIT scores compared with those in the normal group (*P* \< 0.0001 and *P* \< 0.0001, respectively), strongly suggesting that tear film stability was altered in DEG patients. Additionally, the patients in the DEG showed lower corneal sensitivity and severe corneal injury compared with the subjects in the CG (*P* \< 0.0001).

###### 

Demographic and characteristics of study subjects in the control group and dry eye group.

  **Feature**                               **Normal (*n* = 28)**   **Dry eye (*n* = 85)**   ***P* value**
  ----------------------------- ----------- ----------------------- ------------------------ ------------------
  Gender (Female, n(%))                     13 46.4%                35 41.2%                 0.78
  Age (years)                               60.8 ± 11.2             55.4 ± 8.8               \<2.2 × 10^--16^
  HbAlc (%)                                 4.86 ± 0.66             5.446 ± 0.16             0.02
  FBUT (S)                                  12.46 ± 2.03            3.78 ± 1.66              \<2.2 × 10^--16^
  OSDI Scores                               15.36 ± 15.34           24.99 ± 15.28            \<2.2 × 10^--16^
  DEQ-5                                     2.68 ± 2.37             4.95 ± 3.34              \<2.2 × 10^--16^
  FL (\<5 sites)                            28 100.0%               8 9.4%                   \<2.2 × 10^--16^
  SIT (mm)                                  21.7 ± 1.46             7.754 ± 0.53             \<0.0001
  Corneal sensitivity                                                                        
                                Normal      27 96.4%                15 17.6%                 
                                Moderate    1 3.6%                  65 76.5%                 
                                Disappear   0                       5 5.9%                   
  Meibomian gland dysfunction               6 21.4%                 63 74.1%                 
                                Mild        6 100%                  44 69.8%                 
                                Moderate    0                       13 20.6%                 
                                Severe      0                       6 9.6%                   

Non-parametric

t

tests; HbA1c, hemoglobin A1c; OSDI, Ocular Surface Disease Index; FBUT, fluorescein breakup time; DEQ-5, 5-Item Dry Eye Questionnaire; SIT, Schirmer I Test; FL, corneal fluorescein staining.

Association Among Metabolites and Dry Eye Indexes {#S3.SS2}
-------------------------------------------------

The relationship among metabolites and dry eye indexes is demonstrated in [Supplementary Table S2](#TS2){ref-type="supplementary-material"}. The results showed that 37, 991, and 598 metabolic features exerted potential effects on the OSDI, FBUT, and FL, respectively. However, none of the metabolites were significantly associated with the DEQ-5 score, which was lower than the meaningful value in both groups. The LASSO regressions accurately identified the important metabolic biomarker candidates. As shown in [Figures 1A--C](#F1){ref-type="fig"}, 20, 57, and 57 metabolic features were retained for FBUT, OSDI, and FL, respectively. After adjusting for age, sex, and HbA1c levels, 4 of 20 metabolic features remained significant for OSDI, 42 of 57 for FBUT, and 26 of 57 for FL ([Tables 2](#T2){ref-type="table"}--[4](#T4){ref-type="table"}). There is a potential mechanism by which metabolic features are related to OSDI, FBUT, or FL and may contribute to DED. Therefore, the biomarker candidate union set was further modified to confirm the relationship with DED. As shown in [Table 5](#T5){ref-type="table"}, 48 of 51 metabolic features contributed to the incidence of DED. [Figures 2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"} show the 17 increasing and 31 decreasing metabolites by fold change.

![Model for least absolute shrinkage and selection operator (LASSO). Color lines represent the metabolites potentially associated with dry eye. The *x*-axis represents the alpha (cutoff), and the *y*-axis represents the shrink effect value.](fcell-08-00344-g001){#F1}

###### 

The 4 most significant metabolites associated with OSDI among 20 significant metabolites adjusted for age, sex, and HbA1c levels.

  **Metabolite**                         **OR**       **CL**       **CU**       ***t* value**   **P**        **FDR**
  -------------------------------------- ------------ ------------ ------------ --------------- ------------ ------------
  Thiodiacetic acid\*                    1.55247681   1.26158984   1.9104341    4.15516541      3.25E-05     0.0006501
  Uridine\*                              1.40832563   1.14309313   1.73510018   3.21621402      0.00129894   0.01298939
  Octadecanamide\*                       1.3405631    1.09814985   1.63648834   2.8800132       0.00397659   0.02651057
  Phthalic anhydride\*                   0.81766755   0.67425718   0.99158043   −2.0459358      0.04076269   0.20381346
  3-Acrylamidopropyl trimethylammonium   1.19362223   0.98364445   1.44842379   1.79294729      0.07298135   0.28723142
  Triglyme                               1.65924095   0.9305183    2.95865276   1.71595966      0.08616943   0.28723142
  N-Heptane                              1.19858444   0.95035917   1.51164392   1.5299583       0.12602705   0.36007729
  1-Piperidinecarboxaldehyde             1.14944952   0.94898168   1.39226524   1.42445336      0.15431528   0.37131023
  2-Methylbutyroylcarnitine              1.14444901   0.94508279   1.38587174   1.38161611      0.1670896    0.37131023
  Palmitic amide                         0.88257065   0.72651124   1.07215266   −1.2582488      0.20830179   0.41660359
  Diglyme                                0.92001999   0.75985836   1.11394022   −0.8542429      0.39297044   0.68896788
  N-(3-Indolylac etyl)-L-isol eucine     1.08241214   0.89532492   1.30859312   0.81795877      0.41338073   0.68896788
  N,N′-Dicyclohexylurea                  0.94679681   0.77986533   1.14946027   −0.5524484      0.58064115   0.82684503
  (S)-Desoxy-D2PM                        1.05012842   0.86620605   1.27310321   0.49790162      0.61855338   0.82684503
  Tuckolide                              0.95474254   0.78708046   1.1581196    −0.4700638      0.63830943   0.82684503
  Alanyl-Alanine                         0.95900176   0.79513398   1.15664076   −0.4378762      0.66147602   0.82684503
  Dihydroterrein                         0.96411129   0.79540346   1.16860262   −0.3724069      0.70958995   0.83481171
  Indoline                               1.02916604   0.84773779   1.24942257   0.2905526       0.77139351   0.8571039
  N-methyl corydaldine                   1.00723376   0.82432556   1.23072714   0.07049554      0.94379925   0.98564298
  (-)-Corey Lactone Diol                 0.99823666   0.82365976   1.20981561   −0.0179948      0.98564298   0.98564298

OSDI, Ocular Surface Disease Index; HbA1c, hemoglobin A1c; OR, odds ratio; CL, lower of confidence interval; CU, upper of confidence interval. \*

P

\< 0.05.

###### 

The 42 most significant metabolites associated with FBUT out of 57 significant metabolites adjusted of age, sex, and HbA1c level.

  **Metabolite**                                   **OR**       **CL**       **CU**       ***t* value**   **P**        **FDR**
  ------------------------------------------------ ------------ ------------ ------------ --------------- ------------ ------------
  Gamma-Aminobutyric acid\*                        2.31000409   1.72405625   3.09509559   5.60895326      2.04E-08     1.16E-06
  L-Tyrosine\*                                     2.85341036   1.92114399   4.23807415   5.19494456      2.05E-07     5.84E-06
  Oxidized glutathione\*                           1.7939313    1.42065818   2.26528066   4.90996828      9.11E-07     1.73E-05
  Cholesterol\*                                    1.73958267   1.38364581   2.18708274   4.74020998      2.13E-06     3.04E-05
  Glutamate\*                                      1.61563596   1.31307235   1.98791755   4.53449486      5.77E-06     6.58E-05
  fumarate\*                                       0.64862127   0.52991355   0.79392111   --4.1976691     2.70E-05     0.00025619
  Butyrylcarnitine\*                               1.70194948   1.32064315   2.19334955   4.10902868      3.97E-05     0.00032354
  Lactate\*                                        0.65144643   0.52930406   0.80177441   --4.04551       5.22E-05     0.00037199
  Formate\*                                        0.66830153   0.54536283   0.81895375   --3.8856717     0.00010205   0.00062014
  acetylcholine\*                                  0.65827145   0.53212825   0.81431741   --3.8524858     0.00011692   0.00062014
  L-Isoleucine\*                                   1.47248491   1.2089998    1.79339303   3.84678675      0.00011968   0.00062014
  Oleamide\*                                       0.66041693   0.53217629   0.81956023   --3.7664914     0.00016556   0.0007516
  1-Stearoyl-2-Arachidonoyl PC\*                   1.4633179    1.19916256   1.78566222   3.74810872      0.00017817   0.0007516
  Inosine\*                                        2.65048162   1.59011429   4.41795465   3.73920617      0.0001846    0.0007516
  Uracil\*                                         1.46024988   1.19506913   1.7842731    3.70288298      0.00021316   0.00081002
  Uridine\*                                        1.47168572   1.19767109   1.80839204   3.67598012      0.00023694   0.00084409
  Guanine\*                                        1.50029386   1.20718859   1.86456506   3.65785151      0.00025434   0.00085278
  L-Valine\*                                       1.4420049    1.18277435   1.75805143   3.62023335      0.00029434   0.00090405
  Dibutyl phthalate\*                              0.67430255   0.54455312   0.83496708   --3.6141379     0.00030135   0.00090405
  L-Methionine\*                                   1.47026597   1.18226511   1.8284241    3.46527672      0.00052969   0.00150961
  Uracil\*                                         1.42469938   1.15975359   1.75017206   3.37182114      0.00074673   0.00202684
  Cytosine\*                                       0.69994564   0.56654428   0.86475836   --3.306898      0.00094335   0.00244414
  Uridine\*                                        1.40832563   1.14309313   1.73510018   3.21621402      0.00129894   0.00321911
  Squalene\*                                       1.37339911   1.12939739   1.67011642   3.17930202      0.0014763    0.00350622
  L-Kynurenine\*                                   0.72719546   0.59496403   0.88881547   --3.111087      0.001864     0.00417575
  malate\*                                         0.72901762   0.59715129   0.89000341   --3.1046987     0.00190473   0.00417575
  Spermine\*                                       1.35525764   1.11347072   1.64954788   3.03203154      0.00242914   0.00512818
  Citric acid\*                                    0.73919799   0.60698117   0.90021518   --3.0055174     0.00265129   0.00539728
  L-Serine\*                                       1.42722391   1.12895219   1.80429969   2.97402045      0.00293925   0.00577716
  Glucose\*                                        0.73965682   0.60485591   0.90450007   --2.9378068     0.00330543   0.00628032
  Pyroglutamic acid\*                              1.32121764   1.08651926   1.60661307   2.79159771      0.00524485   0.00964376
  pyruvic acid\*                                   0.75616671   0.61730273   0.92626852   --2.6998564     0.00693694   0.01231244
  Adenine\*                                        1.3194087    1.07818635   1.61459967   2.69079233      0.00712826   0.01231244
  Glycocholic acid\*                               0.76903499   0.63133985   0.93676141   --2.6089881     0.00908104   0.0152241
  L-Phenylalanine\*                                0.77952238   0.64158301   0.9471185    --2.506818      0.01218234   0.01983981
  Alpha-dimorphecolic acid\*                       0.76942166   0.62336711   0.94969671   --2.4405653     0.0146643    0.02321847
  Arginine\*                                       0.78958675   0.64748007   0.96288251   --2.3336225     0.0196155    0.03021847
  creatine\*                                       0.79935316   0.6602648    0.96774124   --2.2962044     0.0216642    0.03249629
  glycine\*                                        1.24311063   1.02397819   1.50913765   2.19949186      0.02784297   0.04069357
  Choline\*                                        0.80593633   0.66141539   0.98203547   --2.13979       0.03237174   0.0455426
  Niacinamide\*                                    0.80940226   0.66658792   0.9828141    --2.1350282     0.03275871   0.0455426
  4-Hydroxycitrulline\*                            1.24092841   1.01274466   1.52052476   2.08215659      0.03732817   0.05065966
  PS(20:2(11Z,14Z)/16:0)                           1.21081356   0.99481789   1.47370639   1.90817319      0.05636884   0.0745487
  S-Glutathionyl-L-cysteine                        0.82193434   0.67134384   1.0063041    --1.8991378     0.05754637   0.0745487
  PS(22:4(7Z,10Z,13Z,16Z)/17:0)                    1.2217118    0.96398133   1.5483492    1.65654564      0.09761137   0.12364107
  Oleoyl Oxazolopyridine                           0.85018063   0.69683413   1.03727281   --1.5993885     0.10973431   0.13597512
  Triisobutyl phosphate                            0.85487102   0.70210055   1.04088291   --1.5610858     0.11850352   0.14371703
  2′-Hydroxy-a-naphthoflavone                      0.84884908   0.68885126   1.04600922   --1.5378668     0.12408118   0.14529034
  1-Oleoyl-2-acetyl-sn-glycerol                    0.86144308   0.7120229    1.04221953   --1.5345325     0.12489871   0.14529034
  1,2-Dierucoyl-SN-Glycero-3-Phosphoethanolamine   0.86269924   0.71131474   1.04630193   --1.5002282     0.13355529   0.15225303
  S-Acetyldihydrolipoamide-E                       0.86465346   0.71188448   1.05020635   --1.4661349     0.14261154   0.15938937
  Tetrahydropteroyltri-L-glutamate                 1.14762768   0.94841889   1.3886789    1.41556554      0.15690275   0.17047874
  Streptidine 6-phosphate                          0.87080284   0.71847067   1.05543292   --1.4100825     0.15851532   0.17047874
  Succinoadenosine                                 1.1382523    0.93749381   1.38200198   1.30802614      0.19086444   0.20146802
  PE(16:0/0:0)                                     0.88503301   0.71933451   1.08890011   --1.1547383     0.2481976    0.25722297
  MG(8:2(9Z,12Z)/0:0/0:0)                          0.92122998   0.75599324   1.12258236   --0.8134942     0.41593479   0.4233622
  Tributyl phosphate                               0.95282779   0.77633407   1.16944605   --0.4623322     0.64384309   0.64384309

OR, odds ratio; CL, lower of confidence interval; CU, upper of confidence interval; \*

p

\<0.05.

###### 

The 26 most significant metabolites associated with FL among 57 significant metabolites adjusted for age, sex, and HbA1c levels.

  **Metabolite**                                   **OR**       **CL**       **CU**       ***t* value**   **P**        **FDR**
  ------------------------------------------------ ------------ ------------ ------------ --------------- ------------ ------------
  Betaine\*                                        2.12966068   1.66438833   2.72499784   6.01077856      1.85E-09     1.05E-07
  L-Tyrosine\*                                     2.85341036   1.92114399   4.23807415   5.19494456      2.05E-07     5.84E-06
  Oxidized glutathione\*                           1.7939313    1.42065818   2.26528066   4.90996828      9.11E-07     1.73E-05
  N-Acetylglucosamine\*                            1.6785802    1.35712434   2.07617784   4.77550669      1.79E-06     2.55E-05
  Lithocholic acid\*                               1.53009111   1.24630259   1.8784995    4.06364889      4.83E-05     0.00049599
  Lactate\*                                        0.65144643   0.52930406   0.80177441   −4.04551        5.22E-05     0.00049599
  Pyrrolidonecarboxylic acid\*                     1.4633179    1.19916256   1.78566222   3.74810872      0.00017817   0.00145084
  L-Methionine\*                                   1.47026597   1.18226511   1.8284241    3.46527672      0.00052969   0.00377401
  L-Tryptophan\*                                   1.4145468    1.15893701   1.7265327    3.41056514      0.00064828   0.00378973
  Urocanic acid\*                                  1.40312876   1.15449382   1.70531039   3.40367209      0.00066487   0.00378973
  Uracil\*                                         1.42469938   1.15975359   1.75017206   3.37182114      0.00074673   0.00386942
  \[8\]-Shogaol\*                                  1.40526916   1.14462591   1.72526359   3.25052568      0.00115192   0.00547161
  L-Proline\*                                      0.72332176   0.59365193   0.88131504   −3.2134187      0.00131165   0.00575108
  Purine\*                                         1.39189424   1.12750237   1.71828426   3.07653288      0.00209423   0.00852652
  Glucose\*                                        0.73965682   0.60485591   0.90450007   −2.9378068      0.00330543   0.01256063
  Pyruvic acid\*                                   0.75616671   0.61730273   0.92626852   −2.6998564      0.00693694   0.02390062
  Adenine\*                                        1.3194087    1.07818635   1.61459967   2.69079233      0.00712826   0.02390062
  Alpha-dimorphecolic acid\*                       0.76942166   0.62336711   0.94969671   −2.4405653      0.0146643    0.04643693
  Phenylalanyl-Arginine\*                          1.26891943   1.04241067   1.54464699   2.37402965      0.01759514   0.050412
  Dideoxymycobactin\*                              0.78981126   0.64990349   0.95983763   −2.3720766      0.01768842   0.050412
  Glycerol tripropanoate\*                         1.25491863   1.03820859   1.51686354   2.34767749      0.01889087   0.05127522
  Phenylpyruvic acid\*                             0.77780104   0.62924378   0.96143097   −2.3237225      0.02014037   0.05218187
  Creatine\*                                       0.79935316   0.6602648    0.96774124   −2.2962044      0.0216642    0.05368953
  3-Formylsalicylic acid\*                         1.25266662   1.02631689   1.52893679   2.21546694      0.02672803   0.06347907
  4-oxo-docosanoic acid\*                          1.23158951   1.01314323   1.49713553   2.09107893      0.03652099   0.08183483
  3-Pyrimidin-2-yl-Propionic Acid\*                1.24092841   1.01274466   1.52052476   2.08215659      0.03732817   0.08183483
  Palmitoyl glucuronide                            1.19088225   0.98170979   1.44462299   1.77268467      0.07628097   0.16103761
  N-Acetylvanilalanine                             0.84455515   0.6903238    1.0332447    −1.6421217      0.10056478   0.20472115
  Myristoylcarnitine                               0.85018063   0.69683413   1.03727281   −1.5993885      0.10973431   0.21568467
  PG(P-18:0/0:0)                                   0.84884908   0.68885126   1.04600922   −1.5378668      0.12408118   0.23575425
  3′-Keto-3′-deoxy-AMP                             0.87080284   0.71847067   1.05543292   −1.4100825      0.15851532   0.29095774
  2-glyceryl-PGF2α                                 1.14719977   0.94493723   1.39275634   1.38767768      0.16523521   0.29095774
  Palmitoyl Ethanolamide                           0.87101039   0.71559309   1.06018226   −1.3772039      0.16844922   0.29095774
  Niacinamide                                      0.87638866   0.72270821   1.06274853   −1.3413271      0.17981427   0.30145333
  N-palmitoyl leucine                              0.878715     0.72528806   1.06459778   −1.3206278      0.1866255    0.30393295
  1-Octen-3-yl glucoside                           1.13228205   0.92938045   1.37948095   1.23308906      0.21754254   0.34444235
  Inosine 2′-phosphate                             0.89619591   0.73830719   1.08784949   −1.1084092      0.26768515   0.41237983
  Prosopinine                                      0.91231546   0.74867246   1.11172715   −0.9098758      0.362888     0.52960861
  Tetrandrine                                      0.90727914   0.73483704   1.12018775   −0.9047284      0.36560931   0.52960861
  N-arachidonoyl tyrosine                          1.09225223   0.90000599   1.32556332   0.89337729      0.37165516   0.52960861
  3,7-Dimethyloctanal                              0.92523277   0.76583693   1.11780413   −0.8055564      0.42049868   0.58459572
  3-Amino-L-Tyrosine                               0.92597687   0.76343194   1.1231298    −0.7809123      0.43485409   0.59015912
  PS(12:0/18:3(6Z,9Z,12Z))                         1.07789258   0.88891905   1.30703962   0.76269803      0.4456435    0.59073674
  N-ethyl N-(2-hydroxy-ethyl) arachidonoyl amine   0.92694468   0.75277268   1.14141554   −0.7143992      0.47498035   0.61531545
  Oleoyl Ethanolamide                              0.94634878   0.78134734   1.14619448   −0.5641298      0.57266578   0.70474265
  2-Methyl-1,3-oxathiane                           0.94759109   0.78021615   1.15087193   −0.5428866      0.58720787   0.70474265
  2,8-Dihydroxyadenine                             1.05409689   0.87055921   1.27632932   0.53977667      0.58935106   0.70474265
  3S-Aminodecanoic acid                            1.05316396   0.86678598   1.27961728   0.52128152      0.60217067   0.70474265
  DL-Glycerol 1-phosphate                          1.05456176   0.86186592   1.29034051   0.51603294      0.6058314    0.70474265
  Maprotiline glucuronide                          0.96128301   0.79507038   1.16224306   −0.4076807      0.68350813   0.77919927
  4-Methylene-L-glutamate                          1.03562819   0.84849307   1.26403596   0.34428259      0.73063378   0.8165907
  N,N-Dimethylaniline N-oxide                      1.02864516   0.84885995   1.24650817   0.28815395      0.7732289    0.84757783
  Cystamine                                        1.02490095   0.84205024   1.24745759   0.24531946      0.80620909   0.86705506
  L-Homocysteic acid                               1.02230671   0.83844272   1.24649065   0.21808909      0.8273597    0.8702951
  PI(P-18:0/15:1(9Z))                              0.9801715    0.80721801   1.19018179   −0.2022025      0.83975843   0.8702951
  Propylthiouracil glucuronide                     1.0084228    0.82428505   1.23369524   0.08153469      0.93501674   0.95171346
  Butyl butyryllactate                             0.99823666   0.82365976   1.20981561   −0.0179948      0.98564298   0.98564298

FL, corneal fluorescein staining; HbA1c, hemoglobin A1c; OR, odds ratio; CL, lower of confidence interval; CU, upper of confidence interval. \*

P

\< 0.05.

###### 

The 48 most significant metabolites among 51 metabolites which contributed to the incidence of dry eye.

  **Metabolite**                 **OR**       **CL**       **CU**       **FDR**      **P**        **KEGG**   **HMDB**
  ------------------------------ ------------ ------------ ------------ ------------ ------------ ---------- -------------
  Glutamate\*                    0.15892318   0.05881561   0.42941961   0.00474346   0.00028695   C00025     HMDB0000148
  N-Acetylglucosamine\*          0.33352376   0.18169142   0.61223639   0.00474346   0.00039529   C00140     HMDB0000215
  Urocanic acid\*                0.30038193   0.15246704   0.59179546   0.00474346   0.00050841   C00785     HMDB0000301
  Dibutyl phthalate\*            4.9575756    1.964163     12.512992    0.00474346   0.00070123   C14214     HMDB0033244
  Cholesterol\*                  0.32553998   0.16974262   0.62433511   0.00474346   0.0007306    C00187     HMDB0000067
  fumarate\*                     2.93700184   1.57053771   5.49237356   0.00474346   0.00074232   C00122     HMDB0000134
  Lactate\*                      2.87485838   1.55392837   5.31865616   0.00474346   0.00076742   C00186     HMDB0000190
  L-Tyrosine\*                   0.11616869   0.03287657   0.41047964   0.00474346   0.00082995   C00082     HMDB0000158
  Betaine\*                      0.26844912   0.12382333   0.58199799   0.00474346   0.0008652    C00719     HMDB0000043
  L-Valine\*                     0.34191908   0.18113828   0.6454111    0.00474346   0.00093009   C00183     HMDB0000883
  Amino-n-butyrate\*             0.23891563   0.09963151   0.57291791   0.00575326   0.00133553   NA         NA
  Gamma-Aminobutyric acid\*      0.23879924   0.09944765   0.57341804   0.00575326   0.00135371   C00334     HMDB0000112
  Oxidized glutathione\*         0.38068595   0.20887416   0.69382345   0.00632659   0.00161266   C00127     HMDB0003337
  Thiodiacetic acid\*            0.37739123   0.20461086   0.69607324   0.00653555   0.00180862   C01857     HMDB0031188
  L-Methionine\*                 0.39076767   0.21502082   0.71016085   0.00653555   0.00204947   C00073     HMDB0000696
  Pyrrolidonecarboxylic acid\*   0.36061539   0.18740786   0.69390611   0.00653555   0.00225616   C02237     HMDB0000805
  Octadecanamide\*               0.39764946   0.21949705   0.72039732   0.00653555   0.00235239   C13846     HMDB0034146
  L-Proline\*                    2.71415154   1.42470751   5.17061821   0.00653555   0.00239396   C00148     HMDB0000162
  Inosine\*                      0.11144874   0.02697315   0.46048842   0.00653555   0.00243481   C00294     HMDB0000195
  L-Tryptophan\*                 0.42621286   0.24230821   0.7496956    0.00784822   0.00307773   C00078     HMDB0000929
  Hypoxanthine\*                 0.29993152   0.13456396   0.6685216    0.00785034   0.00323249   C00262     HMDB0000157
  L-Phenylalanine\*              3.67273631   1.51638767   8.89547722   0.00890948   0.0039459    C00079     HMDB0000159
  Purine\*                       0.21222101   0.07380947   0.6101894    0.00890948   0.004018     C15587     HMDB0001366
  Uracil\*                       0.41871956   0.22873078   0.76651719   0.01014436   0.00477382   C00106     HMDB0000300
  Glucose\*                      2.83823315   1.3674437    5.89096821   0.01018904   0.00511095   C00031     HMDB0000122
  Uridine\*                      0.41091757   0.220228     0.76672017   0.01018904   0.00519441   C00299     HMDB0000296
  Cytosine\*                     2.74780932   1.32931549   5.67995794   0.01202255   0.00636488   C00380     HMDB0000630
  Oleamide\*                     2.44685903   1.27149955   4.7087072    0.01344234   0.00738011   C19670     HMDB0002117
  Adenine\*                      0.4549752    0.25202611   0.82135314   0.01578398   0.0089752    C00147     HMDB0000034
  L-Isoleucine\*                 0.46790707   0.26221692   0.83494622   0.01712454   0.0101541    C00407     HMDB0000172
  Squalene\*                     0.2605037    0.09280449   0.73123806   0.01712454   0.01063655   C00751     HMDB0000256
  \[8\]-Shogaol\*                0.46518125   0.25836679   0.83754416   0.01712454   0.01074481   C10494     HMDB0031463
  malate\*                       2.83554082   1.26616827   6.35009732   0.01714406   0.01128604   C00149     HMDB0000156
  creatine\*                     2.17111139   1.19063873   3.95898818   0.01714406   0.01142937   C00300     HMDB0000064
  Niacinamide\*                  5.44745851   1.4046755    21.1257363   0.02073519   0.01423003   C00153     HMDB0001406
  acetylcholine\*                2.1406061    1.12609791   4.06909065   0.02830387   0.02021258   C01996     HMDB0000895
  pyruvic acid\*                 2.33590317   1.13945145   4.78865828   0.02830387   0.02053418   C00022     HMDB0000243
  L-Serine\*                     0.42525807   0.20369022   0.88784051   0.03060053   0.02280039   C00065     HMDB0000187
  Lithocholic acid\*             0.45386319   0.22816228   0.90283021   0.0318622    0.02436521   C03990     HMDB0000761
  Citric acid\*                  2.05194986   1.08127092   3.89402706   0.03553974   0.0278743    C00158     HMDB0000094
  glycine\*                      0.44191416   0.20966057   0.931449     0.03866868   0.03181944   C00037     HMDB0000123
  Spermine\*                     0.34996191   0.1341625    0.91287309   0.03866868   0.0318448    C00750     HMDB0001256
  Guanine\*                      0.59179132   0.36040424   0.97173375   0.04523848   0.03814225   C00242     HMDB0000132
  Alpha-dimorphecolic acid\*     2.04750337   1.03654999   4.0444456    0.04529542   0.0390784    C14767     HMDB0004670
  Formate\*                      2.62276742   1.04426296   6.58733401   0.0455058    0.04015218   C00058     HMDB0000142
  Butyrylcarnitine\*             0.54961227   0.30885677   0.97803797   0.04589771   0.0417985    C02862     HMDB0002013
  L-Kynurenine\*                 1.77187779   1.02008151   3.07774513   0.04589771   0.04229789   C00328     HMDB0000684
  Pyroglutamic acid\*            0.52951971   0.28364654   0.98852298   0.04877657   0.04590736   C01879     HMDB0000267
  Arginine                       3.00381699   0.99530218   9.06550465   0.05306126   0.05098043   C00062     HMDB0000517
  Choline                        1.73881637   0.90931083   3.32502625   0.09630046   0.09441221   C00114     HMDB0000097
  Glycocholic acid               1.32778957   0.78435453   2.24774013   0.29114021   0.29114021   C01921     HMDB0000138

OR, odds ratio; CL, lower of confidence interval; CU, upper of confidence interval. \*

P

\< 0.05.

![The 17 increasing metabolites presented by relative expression in the boxplot. \**P* \< 0.05.](fcell-08-00344-g002){#F2}

![The 31 decreasing metabolites presented by relative expression in the boxplot. \**P* \< 0.05.](fcell-08-00344-g003){#F3}

Trends of Metabolites Related to Dry Eye in Different Age Groups {#S3.SS3}
----------------------------------------------------------------

We analyzed the relationship between metabolites and age. All subjects were grouped into two groups with the age nodes of 50 years (group A ≤ 50, group B \> 50), 55 years (group C ≤ 55, group D \> 55), and 60 years (group E ≤ 60, group F \> 60). The increasing and decreasing metabolites are shown in [Table 6](#T6){ref-type="table"}. In group A, 18 of 48 metabolites did not show significance, and the remaining 30 metabolites showed the same trend in groups A and B. The 18 metabolites were subjected to enrichment and pathway analyses. [Supplementary Figures S1A--C](#FS1){ref-type="supplementary-material"} present the perturbed pathways. The 18 metabolites were related to the aminoacyl-tRNA biosynthesis, glycine, serine, and threonine metabolism, arginine and proline metabolism, valine, leucine, and isoleucine biosynthesis, pantothenate, and Coenzyme A biosynthesis. Comparison of groups C and D revealed that three metabolites (i.e., alpha-dimorphecolic acid, formate, and glycine), which were significant between the CG and DEG, did not show significance in each group. Of note, 39 metabolites showed the same trend in each group. Interestingly, acetylcholine, niacinamide, and pyruvic acid increased only in group D. The only decreasing metabolite in group C was cholesterol, while gamma-aminobutyric acid and L-methionine decreased in group D. In addition, an opposite trend was observed between groups C and D for L-serine. Enrichment and pathway analyses on the six metabolites are shown in [Figures 4A--C](#F4){ref-type="fig"}. The data showed that the perturbed pathways and glutamate, glycine and serine, pyruvaldehyde, degradation, glucose--alanine cycle, and alanine metabolism were related. In the comparison of groups E and F, 10 of 48 metabolites did not show significance in group F, and the remaining 38 metabolites showed the same trend in each group. Enrichment and pathway analyses of the 10 metabolites showed that aminoacyl-tRNA biosynthesis, glycine, serine and threonine metabolism, glyoxylate and dicarboxylate metabolism, tryptophan metabolism, cysteine and methionine metabolism, and glutathione metabolism were involved ([Supplementary Figures S2A--C](#FS2){ref-type="supplementary-material"}).

###### 

The increasing and decreasing metabolites in groups A--F.

  **Group A **≦** 50 Control (*n* = 10), Dry Eye (*n* = 15)**   **Group B \> 50 Control (*n* = 18), Dry Eye (*n* = 70)**   **Group C ≦ 5 Control (*n* = 16), Dry Eye (*n* = 42)**   **Group D \> 55 Control (*n* = 12), Dry Eye (*n* = 43)**   **Group E ≦ 60 Control (*n* = 121), Dry Eye (*n* = 40)**   **Group F \> 60 Control (*n* = 7), Dry Eye (*n* = 45)**                                                                                                                                  
  ------------------------------------------------------------- ---------------------------------------------------------- -------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- --------------------------------------------------------- ------------------- ---------------------- -------------------------- ----------------------------- -------------------------- -----------------------------
  Acetylcholine                                                 Adenine                                                    Acetylcholine                                            \[8\]-shogaol                                              Citric acid                                                \[8\]-shogaol                                             Acetylcholine       \[8\]-shogaol          Acetylcholine              \[8\]-shogaol                 Acetylcholine              \[8\]-shogaol
  Alpha-dimorphecolic acid                                      Amino-n-butyrate                                           Alpha-dimorphecolic acid                                 Adenine                                                    Creatine                                                   Adenine                                                   Citric acid         Adenine                Alpha-dimorphecolic acid   Adenine                       Alpha-dimorphecolic acid   Adenine
  Citric acid                                                   Cholesterol                                                Citric acid                                              Amino-n-butyrate                                           Cystosine                                                  Amino-n-butyrate                                          Creatine            Amino-n-butyrate       Citric acid                Amino-n-butyrate              Citric acid                Amino-n-butyrate
  Cystosine                                                     Glutamate                                                  Creatine                                                 Betaine                                                    Dibutyl Phthalate                                          Betaine                                                   Cystosine           Betaine                Creatine                   Betaine                       Cystosine                  Betaine
  Dibutyl Phthalate                                             Glycine                                                    Cystosine                                                Butyrylcamitine                                            Fumarate                                                   Butyrylcamitine                                           Dibutyl Phthalate   Butyrylcamitine        Cystosine                  Butyrylcamitine               Dibutyl Phthalate          Butyrylcamitine
  Formate                                                       Hypoxanthine                                               Dibutyl Phthalate                                        Cholesterol                                                Glucose                                                    Gamma-Aminobutyric acid                                   Fumarate            Cholesterol            Dibutyl Phthalate          Cholesterol                   Fumarate                   Cholesterol
  Fumarate                                                      Inosine                                                    Formate                                                  Gamma-Aminobutyric acid                                    Lactate                                                    Glutamate                                                 Glucose             Glutamate              Formate                    Gamma-Aminobutyric acid       Glucose                    Gamma-Aminobutyric acid
  Glucose                                                       Lithocholic acid                                           Fumarate                                                 Glutamate                                                  L-Kynurenine                                               Guanine                                                   Lactate             Guanine                Fumarate                   Glutamate                     Lactate                    Glutamate
  Lactate                                                       L-Methionine                                               Glucose                                                  Glycine                                                    L-Phenyl alanine                                           Hypoxanthine                                              L-Kynurenine        Hypoxanthine           Glucose                    Glycine                       L-Phenyl alanine           Hypoxanthine
  L-Phenyl alanine                                              L-tyrosine                                                 Lactate                                                  Guanine                                                    L-Proline                                                  Inosine                                                   L-Phenyl alanine    Inosine                Lactate                    Guanine                       L-Proline                  Inosine
  Malate                                                        Oxidized glutathione                                       L-Kynurenine                                             Hypoxanthine                                               Malate                                                     L-Isoleucine                                              L-Proline           L-Isoleucine           L-Kynurenine               Hypoxanthine                  Malate                     L-Isoleucine
  Oleamide                                                      Purine                                                     L-Phenyl alanine                                         Inosine                                                    Oleamide                                                   Lithocholic acid                                          L-Serine            Lithocholic acid       L-Phenyl alanine           Inosine                       Niacinamide                Lithocholic acid
  Pyruvic acid                                                  Pyroglutamic acid                                          L-Proline                                                L-Isoleucine                                                                                                          L-Methionine                                              Malate              L-Tryptophan           L-Proline                  L-Isoleucine                  Oleamide                   L-Tyrosine
                                                                Pyrrolidonc carboxylic acid                                Malate                                                   Lithocholic acid                                                                                                      L-Serine                                                  Niacinamide         L-Tyrosine             Malate                     Lithocholic acid              Pyruvic acid               L-Valine
                                                                Spermine                                                   Niacinamide                                              L-Methionine                                                                                                          L-Tryptophan                                              Oleamide            L-Valine               Niacinamide                L-Methionine                                             N-Acetylglu cosamine
                                                                Squalene                                                   Oleamide                                                 L-serine                                                                                                              L-Tyrosine                                                Pyruvic acid        N-Acetylglu cosamine   Oleamide                   L-Serine                                                 Octadecanamide
                                                                Urocanic acid                                              Pyruvic acid                                             L-Tryptophan                                                                                                          L-Valine                                                                      Octadecanamide         Pyruvic acid               L-Tryptophan                                             Oxidized glutathione
                                                                                                                                                                                    L-Tyrosine                                                                                                            N-Acetylglu cosamine                                                          Oxidized glutathione                              L-Tyrosine                                               Pyrrolidonc carboxylic acid
                                                                                                                                                                                    L-Valine                                                                                                              Octadecanamide                                                                Purine                                            L-Valine                                                 Spermine
                                                                                                                                                                                    N-Acetylglu cosamine                                                                                                  Oxidized glutathione                                                          Pyroglutamic acid                                 N-Acetylglu cosamine                                     Squalene
                                                                                                                                                                                    octadecanamide                                                                                                        Purine                                                                        Spermine                                          Octadecanamide                                           Thiodiacetic acid
                                                                                                                                                                                    Oxidized glutathione                                                                                                  Pyroglutamic acid                                                             Squalene                                          Oxidized glutathione                                     Uracil
                                                                                                                                                                                    Purine                                                                                                                Pyrrolidonc carboxylic acid                                                   Thiodiacetic acid                                 Purine                                                   Uridine
                                                                                                                                                                                    Pyroglutamic acid                                                                                                     Spermine                                                                      Uracil                                            Pyroglutamic acid                                        Urocanic acid
                                                                                                                                                                                    Pyrrolidonc carboxylic acid                                                                                           Squalene                                                                      Uridine                                           Pyrrolidonc carboxylic acid                              
                                                                                                                                                                                    Spermine                                                                                                              Thiodiacetic acid                                                             Urocanic acid                                     Spermine                                                 
                                                                                                                                                                                    Squalene                                                                                                              Uracil                                                                                                                          Squalene                                                 
                                                                                                                                                                                    Thiodiacetic acid                                                                                                     Uridine                                                                                                                         Thiodiacetic acid                                        
                                                                                                                                                                                    Uracil                                                                                                                Urocanic acid                                                                                                                   Uracil                                                   
                                                                                                                                                                                    Uridine                                                                                                                                                                                                                                               Uridine                                                  
                                                                                                                                                                                    Urocanic acid                                                                                                                                                                                                                                         Urocanic acid                                            

Group A age: ≤50 years, group B age: \>50 years, group C age: ≤55 years, group D age: \>55 years, group E age: ≤60 years, group F age: \>60 years.

![The metabolic pathways involved in dry eye disease at different ages. Six metabolites were subjected to analysis with Metaboanalyst to generate a topology map **(A)**, enrichment analysis network and table for the pathway-associated metabolite sets **(B,C)**.](fcell-08-00344-g004){#F4}

Metabolic Pathways Involved in Dry Eye Disease {#S3.SS4}
----------------------------------------------

For the interpretation of differences in metabolites that may be involved in the pathophysiological mechanism of DED, 17 increasing and 31 decreasing metabolites were subjected to enrichment and pathway analyses. [Figures 5A--C](#F5){ref-type="fig"}, [6A--C](#F6){ref-type="fig"} present the perturbed pathways. In the DEG versus the CG, the increasing metabolites were related to the citrate cycle, nicotinate and nicotinamide, butanoate, arginine-proline, pyruvate, glycolysis or gluconeogenesis, glyoxylate-dicarboxylate, and phenylalanine; the decreasing metabolites were related to glutathione, glycine-serine-threonine, nitrogen, d-glutamine and d-glutamate, and alanine-aspartate-glutamate. Furthermore, we comprehensively analyzed the metabolites that have been associated with DED. As shown in [Figure 7](#F7){ref-type="fig"}, malate, fumarate, niacinamide, L-lactic acid, pyruvic acid, [D]{.smallcaps}-glucose, L-proline, citric acid, L-kynurenine, and L-phenylalanine were significantly elevated along with their metabolic pathways. In contrast, spermine, oxidized glutathione, pyroglutamic acid, urocanic acid, L-valine, L-tyrosine, L-methionine, L-isoleucine, glycine, guanine, adenine, inosine, and uridine were decreased as a result of the inhibition of metabolic pathways. In addition, metabolic enzymes that may be involved in the changes in metabolites are shown in [Figures 5D](#F5){ref-type="fig"}, [6D](#F6){ref-type="fig"}.

![The increasing metabolic pathways involved in dry eye disease. The 17 increasing metabolites were subjected to analysis with Metaboanalyst (<http://www.metaboanalyst.ca>) to generate a topology map **(A)**, enrichment analysis network and table for the pathway-associated metabolite sets **(B,C)**, and enrichment analysis table for the predicted metabolite enzyme sets **(D)**.](fcell-08-00344-g005){#F5}

![The decreasing metabolic pathways involved in dry eye disease. The 31 decreasing metabolites were subjected to analysis with Metaboanalyst to generate a topology map **(A)**, enrichment analysis network and table for the pathway-associated metabolite sets **(B,C)**, and enrichment analysis table for the predicted metabolite enzyme sets **(D)**.](fcell-08-00344-g006){#F6}

![Dry eye disease-related altered metabolic pathway network of the significantly regulated metabolites. Several metabolic pathways of amino acids were activated: tryptophan, arginine-proline, and cysteine-methionine metabolism. Notably, phenylalanine-tyrosine-tryptophan biosynthesis, glycine-serine-threonine metabolism, and valine-leucine-isoleucine biosynthesis were decreased. The increased levels of malate, citric acid, fumarate, and lactic acid indicated significant elevation of the tricarboxylic acid (TCA) cycle and glycolysis or gluconeogenesis. Metabolites of adenine, guanine, and inosine were significantly inhibited, suggesting decreased purine metabolism. Histidine and glutathione metabolism was inhibited, indicated by a decrease in urocanic acid, pyroglutamic acid, oxidized glutathione, and spermine. Pyrimidine metabolism was inhibited as indicated by the levels of uridine and uracil.](fcell-08-00344-g007){#F7}

Discussion {#S4}
==========

Dry eye disease is an ocular surface disorder in which the tear film is unstable due to multiple factors ([@B9]). Studying changes in the chemical composition of tears is the most direct approach to exploring the mechanism of dry eye development. In an early study conducted by [@B32] using the protein quantification method, statistically significant differences in the protein ratios were detected between the normal and dry eye groups. [@B21] underscored the pathological relevance of structure-specific alterations in tear lipid components, particularly wax esters, to the pathogenesis of DED. In recent years, an increasing number of research studies have been devoted to identifying differential biomarker candidates. [@B27] compared tears between aqueous-deficient, evaporative dry eye patients and healthy subjects, showing that 13 major proteins were differentially expressed. A similar study performed by [@B16] ascertained the differential expression profiles of 18 proteins (*P* \< 0.05) with a fast proteomic method based on LC-quadrupole-orbitrap-MS analysis.

The global-omics platform has been widely used in the study of the tear proteome and lipidome ([@B21]). However, the analysis of tear metabolites is limited to the analysis of targeted compound classes, and the number of identified metabolites is also markedly lower than that of other biomolecules identified in tears. This observation may be attributed to challenges in instrument sensitivity, as the typical sample volume of tears is only 5--10 μl. [@B13] suggested for the first time that the severity of dry eye exerts a significant effect on tear metabolism, suggesting that the tear metabolome may be utilized to identify biomarker candidates and surrogate endpoints for DED. In this study, we improved the utilization of tears by optimizing the collection of samples and using high-resolution MS. Previous research directly compared the statistically significant increase or decrease of chemicals between tears of patients with DED and healthy subjects ([@B14]). We used the LASSO algorithm, which refers to the variable selection method (minimizing the log partial to the sum of the absolute values of the parameters being bounded by a constant) to identify the significant metabolites associated with DED.

By focusing on the union of the sets of metabolites that were correlated with the OSDI, FBUT, and FL, we confirmed 48 significantly different metabolites between the DEG and CG. As previously reported, the major metabolites were amino acids, carbohydrates, and lipids ([@B6]; [@B8]; [@B26]; [@B29]; [@B43]). Firstly, increased levels of glucose ([@B34]), lactate ([@B30]), and creatine ([@B43]) have been reported in patients with dry eye, suggesting that these patients may be in a state of high energy metabolism. However, glutathione, cholesterol, and N-acetylglucosamine were noticeably decreased in the DEG versus the CG. In addition, previous proteomics studies in patients with dry eye reported that the lower expression of lactoferrin, lipocalin, and lipophilin AC-1 ([@B3]) may render these patients more susceptible to infections because of the increased oxidative stress and reduced antimicrobial proteins ([@B31]). Moreover, the levels of kynurenine increased as a result of the catabolism of tryptophan, which is involved in the inflammatory mechanisms of Sjögren's syndrome with dry eye ([@B10]).

Various adenine and uracil nucleotides have been shown to improve corneal barrier function and increase both tear fluid secretion and corneal epithelial resistance ([@B12]). [@B20] reported that pyrimidine nucleoside uridine exerts a protective effect on cultured human corneal epithelial cells in an animal model of dry eye and in patients. Our results showed that decreased levels of adenine, uridine, pyrimidine, and uracil may contribute to lower corneal sensitivity.

[@B11] clearly demonstrated that aging is a risk factor for dry eye, and the mechanism of age-related increase in the incidence of DED has also been elucidated. Interestingly, when we grouped all patients according to different age nodes, various changes were observed. The analysis revealed that the basal secretion of human tears decreased with the increase of age; we found that acetylcholine in tears was significantly increased in group D and can activate the muscarinic receptor to cause reflex secretion of tears ([@B24]), which may be a kind of negative feedback regulation. [@B36] found that nicotinamide and pyruvate accumulated to higher levels in old mice, and cholesterol was significantly lower in the aged cornea, while 1-methylNAA may be a hallmark for the aging eye. Notably, 1-methylNAA is produced by N-methyltransferase, transferring methyl groups from S-adenosylmethionine to nicotinamide ([@B36]), which is consistent with the high expression of nicotinamide and pyruvic acid, and the low expression of cholesterol in group D. In addition, taurine is one of the most abundant amino acids in the retina ([@B22]), cornea, and lens. The levels of taurine in the rat cornea and lens decrease with age ([@B39]), and the main pathway of taurine biosynthesis is methionine and cysteine. Hence, we infer that the reduction in L-methionine may be related to taurine metabolism. [@B15] revealed that serine is involved in lipid metabolism and thus affects mitochondrial metabolism. Dry eye is also closely related to lipid metabolism; however, the mechanism of change in the levels of serine remains unclear. It is well established that gamma-aminobutyric acid is an important inhibitory neurotransmitter in the central nervous system and plays an important role in tissue development and biological signal communication; however, its mechanism of action in the ocular surface remains unknown. Regarding the three metabolites not exhibiting any trend, we found that their *P*-values prior to grouping were close to 0.05. Therefore, we hypothesized that the test effect may be influenced by the change in sample size after grouping. In addition, 18 of 48 metabolites in group A, seven of 48 in group C, five of 48 in group D, and 10 of 48 in group F did not show significance, indicating that the expression of metabolites related to dry eye changed with age. Based on the number of metabolites which did not show significance in each group, we can infer that the metabolites related to the dry eye significantly increase from the age of 50 years. This is consistent with the findings of the TFOS DEWS II Epidemiology Report ([@B33]). Moreover, the number of meaningful metabolites related to dry eye was greater between the age of 50 and 60 years, which indirectly reflected the relationship between the symptoms of dry eye and age. At the age of 50--60 years, when the patients experience the most obvious symptoms of dry eye, and with increasing age, the sensitivity appears to be decreasing. This effect may be related to weakened corneal perception. The metabolic pathways associated with differential metabolites in different groups are partly different, which may be related to different endocrine levels at each age. However, the mechanism involved in this process is unclear.

A number of reports have been published in recent years on the components of tears. However, differences in the collection method, the instrument for the detection of metabolites, and the technique used for the metabolomic analysis contribute to the discrepancies observed between the reports. Our study had several limitations. Firstly, there was a significant difference in age between the CG and the DEG; however, the appropriate statistical procedure was performed to adjust for age. Secondly, our study did not analyze the different metabolites in the dry eye subgroups. Precise statistical analyses were essential to guarantee the consistency of our data.

In summary, metabolomics can be used to extract molecular information from human tears. This information can be useful for the accurate diagnosis of DED, prediction of prognosis, and development of personalized therapies. Our data demonstrated the different metabolomic profiles between individuals with and without dry eye and between different age groups. Furthermore, they partly illustrate the relationship between changes in metabolites, symptoms in dry eye, and age.
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The metabolic pathways involved in dry eye disease at different ages. Eighteen metabolites were subjected to analysis with Metaboanalyst to generate a topology map **(A)**, enrichment analysis network and table for the pathway-associated metabolite sets **(B,C)**.
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The metabolic pathways involved in dry eye disease at different ages. Ten metabolites were subjected to analysis with Metaboanalyst to generate a topology map **(A)**, enrichment analysis network and table for the pathway-associated metabolite sets **(B,C)**.
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The relationship between metabolites and dry eye indexes. OSDI, Ocular Surface Disease Index; FBUT, fluorescein breakup time; DEQ-5, 5-Item Dry Eye Questionnaire; FL, corneal fluorescein staining; OR, odds ratio; CL, lower of confidence interval; CU, upper of confidence interval.
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